These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9168374)

  • 1. The estrogen component of OCs: cardiovascular benefits and risks.
    Burkman RT
    Int J Fertil Womens Med; 1997; Suppl 1():145-57. PubMed ID: 9168374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OC practice guidelines: minimizing side effects.
    Darney PD
    Int J Fertil Womens Med; 1997; Suppl 1():158-69. PubMed ID: 9168375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral contraception, glucid metabolism and monitoring criteria].
    Gaspard U
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
    Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraception and coronary heart disease.
    Oliver MF
    Eur Heart J; 1983 Jan; 4(1):6-8. PubMed ID: 6832178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen component of OCs.
    Kaunitz AM; Ory H
    Dialogues Contracept; 1997; 5(4):1-6. PubMed ID: 12293158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for a lower dose pill. Assessing the impact of estrogen dose.
    Brown S; Cropfield O
    ORGYN; 1995; (2):36-9. PubMed ID: 12319251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contraception: evolution of concepts over the last thirty years].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraception and carbohydrate metabolism: III--practical implications].
    Hilal M
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and MI: how strong is the link?
    Jick H
    J Cardiovasc Med; 1982 May; 7(5):481, 484-5. PubMed ID: 12311565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and hypertension.
    Weinberger MH
    Compr Ther; 1982 Jun; 8(6):71-5. PubMed ID: 7105645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.